サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/02/16 | 3,620 | 3,690 | 3,435 | 3,470 | -125 | -3.5% | 705,400 |
| 2018/02/15 | 3,305 | 3,680 | 3,300 | 3,595 | +230 | +6.8% | 936,300 |
| 2018/02/14 | 3,205 | 3,445 | 3,195 | 3,365 | +125 | +3.9% | 629,100 |
| 2018/02/13 | 3,545 | 3,560 | 3,240 | 3,240 | -235 | -6.8% | 626,000 |
| 2018/02/09 | 3,040 | 3,485 | 3,015 | 3,475 | +15 | +0.4% | 1,070,100 |
| 2018/02/08 | 3,600 | 3,670 | 3,415 | 3,460 | ±0 | ±0% | 1,162,000 |
| 2018/02/07 | 3,800 | 4,085 | 3,425 | 3,460 | +45 | +1.3% | 1,733,000 |
| 2018/02/06 | 3,830 | 3,930 | 3,410 | 3,415 | -695 | -16.9% | 1,919,600 |
| 2018/02/05 | 4,015 | 4,150 | 3,955 | 4,110 | -55 | -1.3% | 607,900 |
| 2018/02/02 | 4,255 | 4,285 | 4,055 | 4,165 | -45 | -1.1% | 417,700 |
| 2018/02/01 | 4,095 | 4,230 | 4,045 | 4,210 | +185 | +4.6% | 443,100 |
| 2018/01/31 | 4,130 | 4,270 | 4,025 | 4,025 | -190 | -4.5% | 599,600 |
| 2018/01/30 | 4,035 | 4,265 | 3,980 | 4,215 | +110 | +2.7% | 904,300 |
| 2018/01/29 | 4,405 | 4,420 | 4,080 | 4,105 | -290 | -6.6% | 879,000 |
| 2018/01/26 | 4,495 | 4,565 | 4,365 | 4,395 | -60 | -1.3% | 884,100 |
| 2018/01/25 | 4,250 | 4,460 | 4,190 | 4,455 | +230 | +5.4% | 803,300 |
| 2018/01/24 | 4,190 | 4,305 | 4,135 | 4,225 | -5 | -0.1% | 633,200 |
| 2018/01/23 | 4,165 | 4,365 | 4,140 | 4,230 | +120 | +2.9% | 975,200 |
| 2018/01/22 | 4,005 | 4,125 | 3,940 | 4,110 | +215 | +5.5% | 639,400 |
| 2018/01/19 | 3,930 | 4,145 | 3,825 | 3,895 | -55 | -1.4% | 958,400 |
| 2018/01/18 | 3,775 | 4,195 | 3,745 | 3,950 | +165 | +4.4% | 1,211,600 |
| 2018/01/17 | 3,560 | 3,785 | 3,485 | 3,785 | +215 | +6% | 619,600 |
| 2018/01/16 | 3,605 | 3,680 | 3,475 | 3,570 | -45 | -1.2% | 632,300 |
| 2018/01/15 | 3,365 | 3,635 | 3,260 | 3,615 | +265 | +7.9% | 755,300 |
| 2018/01/12 | 3,400 | 3,415 | 3,325 | 3,350 | -25 | -0.7% | 249,600 |
| 2018/01/11 | 3,295 | 3,400 | 3,270 | 3,375 | +80 | +2.4% | 421,400 |
| 2018/01/10 | 3,205 | 3,325 | 3,170 | 3,295 | +80 | +2.5% | 358,600 |
| 2018/01/09 | 3,065 | 3,230 | 3,065 | 3,215 | +100 | +3.2% | 418,900 |
| 2018/01/05 | 3,150 | 3,160 | 3,060 | 3,115 | -70 | -2.2% | 367,900 |
| 2018/01/04 | 3,290 | 3,290 | 3,160 | 3,185 | -40 | -1.2% | 446,700 |
| 2017/12/29 | 3,200 | 3,295 | 3,180 | 3,225 | +10 | +0.3% | 254,800 |
| 2017/12/28 | 3,320 | 3,430 | 3,195 | 3,215 | -85 | -2.6% | 648,300 |
| 2017/12/27 | 3,190 | 3,305 | 3,165 | 3,300 | +175 | +5.6% | 574,600 |
| 2017/12/26 | 3,125 | 3,150 | 3,075 | 3,125 | +50 | +1.6% | 247,700 |
| 2017/12/25 | 3,190 | 3,190 | 3,050 | 3,075 | -55 | -1.8% | 311,100 |
| 2017/12/22 | 3,080 | 3,195 | 3,030 | 3,130 | +35 | +1.1% | 501,800 |
| 2017/12/21 | 3,085 | 3,145 | 3,040 | 3,095 | -45 | -1.4% | 246,300 |
| 2017/12/20 | 3,105 | 3,235 | 3,050 | 3,140 | +50 | +1.6% | 296,300 |
| 2017/12/19 | 3,150 | 3,210 | 3,000 | 3,090 | -55 | -1.7% | 489,500 |
| 2017/12/18 | 3,330 | 3,340 | 3,065 | 3,145 | -170 | -5.1% | 713,100 |
| 2017/12/15 | 3,365 | 3,440 | 3,230 | 3,315 | -45 | -1.3% | 780,900 |
| 2017/12/14 | 3,220 | 3,430 | 3,040 | 3,360 | +245 | +7.9% | 1,425,800 |
| 2017/12/13 | 3,050 | 3,300 | 3,040 | 3,115 | +65 | +2.1% | 886,100 |
| 2017/12/12 | 3,010 | 3,130 | 2,996 | 3,050 | +20 | +0.7% | 310,300 |
| 2017/12/11 | 3,070 | 3,085 | 2,994 | 3,030 | ±0 | ±0% | 239,800 |
| 2017/12/08 | 2,985 | 3,040 | 2,910 | 3,030 | -20 | -0.7% | 588,900 |
| 2017/12/07 | 3,140 | 3,190 | 2,984 | 3,050 | +35 | +1.2% | 551,300 |
| 2017/12/06 | 3,000 | 3,170 | 2,898 | 3,015 | +127 | +4.4% | 1,108,400 |
| 2017/12/05 | 3,015 | 3,040 | 2,873 | 2,888 | -167 | -5.5% | 875,500 |
| 2017/12/04 | 2,875 | 3,220 | 2,865 | 3,055 | +252 | +9% | 1,307,000 |
1751～
1800
件表示中 / 2451件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 227,900円 | - | - | 0.00% | - | 105.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 407,700円 | +30.5% | +111.0% | 4.66% | 11.49倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 375,500円 | +14.5% | -2.3% | 2.40% | 13.73倍 | 0.73倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 251,500円 | +15.0% | -7.3% | 2.78% | 8.25倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 449,500円 | +7.1% | -35.0% | 2.67% | 37.17倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
